Combination HIV pill might be available in 2006

01/11/2006 | Los Angeles Times (tiered subscription model)

Gilead CEO John Martin says the triple combination HIV pill, to be sold with Bristol-Myers Squibb and Merck, may be on the market this year. Martin says his company will file with the FDA during the second quarter for approval of the drug, the first to combine three HIV medicines in a once-a-day pill.

View Full Article in:

Los Angeles Times (tiered subscription model)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD